BACKWARD BIFURCATION IN A MATHEMATICAL MODEL OF PI3K/AKT PATHWAYS IN ACUTE MYELOID LEUKEMIA

被引：1

作者：

Adi, Yudi Ari ^{[1
,2
]}

Aryati, Lina ^{[2
]}

Adi-Kusumo, Fajar ^{[2
]}

Hardianti, Mardiah Suci ^{[3
]}

机构：

[1] Univ Ahmad Dahlan, Fac Appl Sci & Technol, Dept Math, Yogyakarta 55191, Indonesia

[2] Univ Gadjah Mada, Fac Math & Nat Sci, Dept Math, Yogyakarta 55281, Indonesia

[3] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Internal Med, Yogyakarta 55281, Indonesia

来源：

ADVANCES IN DIFFERENTIAL EQUATIONS AND CONTROL PROCESSES | 2019年 / 21卷 / 02期

关键词：

AML; mathematical model; backward bifurcation;

D O I：

10.17654/DE021020183

中图分类号：

O29 [应用数学];

学科分类号：

070104 ;

摘要：

This paper investigates a mathematical model of the PI3K/AKT pathway in acute myeloid leukemia (AML) in the absence of protein dephosphorylation and AKT degradation. We perform a bifurcation analysis by using the bifurcation method, which is based on the use of the center manifold theory. We give an explicit condition for the existence of backward and forward bifurcations. Numerical simulations are presented to support analytical results and then discussed from both the mathematical and the medical perspectives.

引用

页码：183 / 199

页数：17

共 50 条

[41] Salvianolic acid A, a novel PI3K/Akt inhibitor, induces cell apoptosis and suppresses tumor growth in acute myeloid leukemia
Pei, Renzhi
Si, Ting
Lu, Ying
Zhou, Jeff Xiwu
Jiang, Lei
LEUKEMIA & LYMPHOMA, 2018, 59 (08) : 1959 - 1967
[42] Targeting PI3K/AKT/mTOR network for treatment of leukemia
Bertacchini, Jessika
Heidari, Nazanin
Mediani, Laura
Capitani, Silvano
Shahjahani, Mohammad
Ahmadzadeh, Ahmad
Saki, Najmaldin
CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (12) : 2337 - 2347
[43] Targeting PI3K/AKT/mTOR network for treatment of leukemia
Jessika Bertacchini
Nazanin Heidari
Laura Mediani
Silvano Capitani
Mohammad Shahjahani
Ahmad Ahmadzadeh
Najmaldin Saki
Cellular and Molecular Life Sciences, 2015, 72 : 2337 - 2347
[44] Influence of PI3K/AKT pathway on imatinib mesylate treatment outcome in chronic myeloid leukemia patients
Banapuram, Swathi
Gorre, Manjula
Digumarti, Raghunadha Rao
Satti, Vishnupriya
Palle, Komaraiah
Annamaneni, Sandhya
CANCER RESEARCH, 2020, 80 (16)
[45] Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia
He, Ying
Ding, Jiyuan
Liu, Liqin
Chen, Jiajun
Zhong, Hong
Li, Changyu
Xu, Xiaofeng
ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5285 - 5296
[46] Genome-Wide CRISPR Screening in Acute Myeloid Leukemia Cells Identifies Genes in the PI3K/AKT/mTOR and MEK/ERK Pathways That Define Sensitivity to Trametinib
Nechiporuk, Tamilla
Damnernsawad, Alisa
Bottomly, Daniel
Morrow, Quinlan
Choi, Suyoun
Beer, Sofia
Kurtz, Stephen E.
McWeeney, Shannon K.
Tyner, Jeffrey W.
BLOOD, 2019, 134
[47] PI3K/AKT/mTOR
Umemura, Shigeki
Goto, Koichi
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
[48] Bakkenolide A inhibits leukemia by regulation of HDAC3 and PI3K/Akt-related signaling pathways
Zhang, Lei
Hong, Ze
Zhang, Rong-Rong
Sun, Xing-Zhen
Yuan, Yu-Fang
Hu, Jian
Wang, Xiang
BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 958 - 966
[49] Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism
Wang, Lingcong
Wu, Jiannong
Zhang, Wei
Zhi, Yihui
Wu, Yanchun
Jiang, Ronglin
Yang, Ruhui
MOLECULAR MEDICINE REPORTS, 2013, 8 (05) : 1465 - 1471
[50] I-B KINASE OVERCOMES PI3K/AKT AND ERK/MAPK TO CONTROL FOXO3A ACTIVITY IN ACUTE MYELOID LEUKEMIA
Chapuis, N.
Park, S.
Leotoing, L.
Tamburini, J.
Verdier, F.
Bardet, V.
Green, A.
Willems, L.
Agou, F.
Ifrah, N.
Dreyfus, F.
Bismuth, G.
Baud, V.
Mayeux, P.
Lacombe, C.
Bouscary, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 23 - 23

← 1 2 3 4 5 →